The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Perindopril Krka 8 mg tablets

8 milligram(s) Tablet

Krka d.d., Novo mestoPA1347/041/003

Main Information

Trade NamePerindopril Krka 8 mg tablets
Active SubstancesPerindopril tert-butylamine
Strength8 milligram(s)
Dosage FormTablet
Licence HolderKrka d.d., Novo mesto
Licence NumberPA1347/041/003

Group Information

ATC CodeC09AA ACE inhibitors, plain
C09AA04 perindopril

Status

Authorised/WithdrawnAuthorised
Licence Issued06/08/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListPerindopril 8mg Tablets
Interchangeable List CodeIC0002-009-002
Interchangeable List DocumentPDF of Interchangeable List
« Back